Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541104
PUBLISHER: IMARC | PRODUCT CODE: 1541104
Respiratory Syncytial Virus Diagnostics Market Report by Product, End Use, and Region 2024-2032
PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global respiratory syncytial virus (RSV) diagnostics market size reached US$ 1,005.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,072.3 Million by 2032 exhibiting a growth rate (CAGR) of 8.1% during 2024-2032.
Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which can cause asthma, hospitalization, pneumonia, repeated infections, middle ear infection, and death. It can be diagnosed using blood tests, chest x-rays, a swab of secretions, and pulse oximetry by checking for signs like lung inflammation, white blood cell (WBC) count, and oxygen levels in the blood. Some of the commonly available treatment options for RSV are over-the-counter (OTC) medications, intravenous (IV) fluids, humidified oxygen, mechanical ventilation, and inhaled bronchodilators.
Respiratory Syncytial Virus (RSV) Diagnostics Market Trends:
RSV infection can be more serious during the neonatal period as children under two years of age tend to develop severe respiratory symptoms. This, in confluence with the rising focus of parents on child medical care, represents one of the crucial factors fostering the growth of the market. Moreover, the high survival rates after early diagnosis and the easy availability of diagnostic modalities act as other growth-inducing factors. Apart from this, the improving healthcare infrastructure and favorable reimbursement policies for the treatment of hospitalized infants are also contributing to market growth. Furthermore, the advent of advanced techniques like bio- and nanotechnology is facilitating the development of modern detection systems for RSV, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). Besides this, governing agencies of numerous countries are funding research and development (R&D) projects for the development of new therapeutics. Other factors projected to drive the market are the growing number of clinical vaccine trials, the escalating demand for in-vitro diagnostics, rising incidences of childhood pneumonia and the increasing adoption of molecular diagnostics.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory syncytial virus (RSV) diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end use.
Breakup by Product:
Direct Fluorescent Antibody (DFA) Method
Rapid Antigen Diagnostic Test (RADTs)
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Others
Breakup by End Use:
Hospitals and Clinics
Laboratory
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global respiratory syncytial virus (RSV) diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global respiratory syncytial virus (RSV) diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global respiratory syncytial virus (RSV) diagnostics market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A4048
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Direct Fluorescent Antibody (DFA) Method
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Rapid Antigen Diagnostic Test (RADTs)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Molecular Diagnostics
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Chromatographic Immunoassay
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Diagnostic Imaging
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Gel Microdroplets
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Flow Cytometry
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Others
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
7 Market Breakup by End Use
- 7.1 Hospitals and Clinics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Laboratory
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Becton, Dickinson and Company
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 bioMerieux SA
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Bio-Rad Laboratories Inc.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Coris BioConcept
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6 DiaSorin Molecular LLC (DiaSorin Inc)
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.7 F. Hoffmann-La Roche AG
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 SWOT Analysis
- 13.3.8 Merck KGaA
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Quest Diagnostics Incorporated
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Quidel Corporation
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.11 Thermo Fisher Scientific Inc.
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.1 Abbott Laboratories
Product Code: SR112024A4048
List of Figures
- Figure 1: Global: Respiratory Syncytial Virus Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Product (in %), 2023
- Figure 5: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by End Use (in %), 2023
- Figure 6: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Region (in %), 2023
- Figure 7: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 8: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 9: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: North America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: North America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: United States: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: United States: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Canada: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Canada: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: China: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: China: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Japan: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Japan: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: India: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: India: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: South Korea: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: South Korea: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Australia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Australia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Indonesia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Indonesia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Europe: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Europe: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Germany: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Germany: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: France: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: France: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: United Kingdom: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: United Kingdom: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Italy: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Italy: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Spain: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Spain: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Russia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Russia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Latin America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Latin America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Brazil: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Brazil: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Mexico: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Mexico: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Breakup by Country (in %), 2023
- Figure 77: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Global: Respiratory Syncytial Virus Diagnostics Industry: SWOT Analysis
- Figure 79: Global: Respiratory Syncytial Virus Diagnostics Industry: Value Chain Analysis
- Figure 80: Global: Respiratory Syncytial Virus Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Respiratory Syncytial Virus Diagnostics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2024-2032
- Table 4: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 5: Global: Respiratory Syncytial Virus Diagnostics Market: Competitive Structure
- Table 6: Global: Respiratory Syncytial Virus Diagnostics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.